Alzamend Neuro
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Alzamend Neuro
Alzamend Neuro, Inc. 是一家早期臨床階段的生物製藥公司，專注於開髮用於治療神經退行性疾病和精神疾病的各種產品。該公司的產品線包括正在進行 II 期臨床試驗的 AL001，它提供鋰、脯氨酸和水楊酸鹽的治療組合，用於治療阿爾茨海默氏症、雙相情感障礙、創傷後應激障礙、重度抑鬱症、其他神經退行性疾病、和精神疾病；以及完成臨床前階段的AL002，採用突變肽致敏細胞作為細胞治療性疫苗的方法，恢復患者免疫系統對抗阿爾茨海默病的能力。 Alzamend Neuro, Inc.成立於2016年，總部位於佐治亞州亞特蘭大。
如何購買 Alzamend Neuro (ALZN)
登入
1分鐘開戶
僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助，支援 RockFlow App 和網頁端操作。
充值資金
帳戶驗證完成後，您可以使用首選的支付方式向帳戶充值。
購買 ALZN
透過 RockFlow App 或網頁端搜尋 ALZN，輸入您想要投資的金額，然後點擊確認即可完成交易。
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.